Sort
53,477 grants matching “addiction”
Training and Education Core p270-287
$740,279Thomas Evan Eissenberg · Virginia Commonwealth University · P50 · FY2014 · DA
Impact of Drug Policy Reform on the HIV Risk Environment among IDUs in Tijuana
$739,992Steffanie A Strathdee · University Of California, San Diego · R37 · FY2015 · DA
Rural Comorbidity and HIV consequences of Opioid use Research and Treatment Initiative (Rural cohort)
$739,908Heidi M. Crane · University Of Washington · U24 · FY2022 · DA
Cannabinergic Medications for Methamphetamine Addiction
$739,906Alexandros Makriyannis · Northeastern University · R37 · FY2015 · DA
Functional and histological changes to peripheral innervation following spinal cord stimulation in patients with painful diabetic neuropathy
$739,792Kristy L Townsend · Ohio State University · R01 · FY2025 · DK
Functional and histological changes to peripheral innervation following spinal cord stimulation in patients with painful diabetic neuropathy
$739,792Kristy L Townsend · Ohio State University · R01 · FY2023 · DK
FMRI Dynamic Phantom for ImprovedDetection of Resting-ÂâState Brain Networks
$739,716Alan Kriegstein · Ala Scientific Instruments, Inc. · R44 · FY2019 · DA
Research Support Core D: Clinical and Behavioral Services
$739,688Ann K Avery · Case Western Reserve University · P30 · FY2021 · DA
The circadian rhythm as a lentiviral vector restriction factor
$739,656Tal Kafri · Univ Of North Carolina Chapel Hill · R01 · FY2022 · HL
Non-Invasive Vagal Nerve Stimulation in Patients with Opioid Use Disorders
$739,505James Douglas Bremner · Emory University · UG3 · FY2020 · DA
Mechanism of Action of a Novel Golgi-Targeted Anti-Cancer Agent
$739,493Seth J Field · Case Western Reserve University · R01 · FY2020 · CA
Cerebellum and Addiction
$739,434Kamran Khodakhah · Albert Einstein College Of Medicine · R01 · FY2020 · DA
Cerebellum and Addiction
$739,434Kamran Khodakhah · Albert Einstein College Of Medicine · R01 · FY2021 · DA
Cerebellum and Addiction
$739,434Kamran Khodakhah · Albert Einstein College Of Medicine · R01 · FY2019 · DA
BUP - BOOSTeR: Behavioral Optimization for Overcoming Suboptimal Treatment Retention
$739,353Michael D Stein · Boston University Medical Campus · R01 · FY2025 · DA
Evaluation Of Treatments Of Opioid And Cocaine Dependence
$739,328Kenzie Preston · National Institute On Drug Abuse · ZIA · FY2011 · DA
Ohio Valley Node-Network (OVNN) of the NIDA Clinical Trials Network
$739,260T John Winhusen · University Of Cincinnati · UG1 · FY2018 · DA
The effects of exposure to violence on risk for substance abuse: neural mechanisms and community level moderators
$739,195Baldwin M Way · Ohio State University · R01 · FY2022 · DA
Opioid therapy for pain in individuals with metastatic cancer: benefits, harms and stakeholder perspectives
$739,175Jessica S Merlin · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · NR
RAE (Realize, Analyze, Engage)- A Digital Biomarker Based Detection and Intervention System for Stress and Craving During Recovery from Substance Abuse Disorders
$739,128Megan Rois Reinhardt · Continueyou, Llc · R44 · FY2021 · DA
HIV Infection, Cocaine Use and Coronary Artery Disease in HIV+ African Americans
$738,957Shenghan Lai · Johns Hopkins University · R01 · FY2011 · DA
Mindful Body Awareness Training as an Adjunct to Medication Assisted Treatment for Opioid Use Disorder
$738,950Cynthia J Price · University Of Washington · R33 · FY2020 · AT
Clinical Research Resources and Facilities
$738,872Judith E Feinberg · West Virginia University · U54 · FY2021 · GM
Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention
$738,773Lynn Elizabeth Fiellin · Yale University · R01 · FY2011 · AA
Development of I-THP as New Medication for Drug Addiction (DP1)
$738,720Jia Bei Wang · University Of Maryland Baltimore · DP1 · FY2013 · DA